Current Systemic Treatment Options in Metastatic Urothelial Carcinoma after Progression on Checkpoint Inhibition Therapy-A Systemic Review Combined with Single-Group Meta-Analysis of Three Studies Testing Enfortumab Vedotin.

Susanne DeiningerPeter TörzsökDavid OswaldLukas Lusuardi

Published in: Cancers (2021)

Most data are currently available for EV. Further research is needed on the question of which patients' subcollectives particularly benefit from which therapeutic approach.

Keyphrases

systematic review
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
squamous cell carcinoma
small cell lung cancer
case control
dna damage
peritoneal dialysis
cell cycle
stem cells
big data
electronic health record
cell proliferation
mesenchymal stem cells
bone marrow
patient reported